Related Experiment Video

Updated: Jul 16, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

Considerations in the rational design and conduct of phase I/II pediatric clinical trials: avoiding the problems and

S M Abdel-Rahman1, M D Reed, T G Wells

  • 1Division of Pediatric Clinical Pharmacology and Medical Toxicology, The Children's Mercy Hospitals and Clinics, Kansas City, Missouri, USA. srahman@cmh.edu

Clinical Pharmacology and Therapeutics
|March 3, 2007
PubMed

Insights

Pediatric drug development requires careful trial design. Ensuring trained pediatric investigators are involved in designing and interpreting phase I/II clinical trials is crucial for patient safety and effective research.

Area of Science:

  • Pediatric Pharmacology
  • Clinical Trial Design
  • Drug Development

Background:

  • Growing awareness necessitates including children in drug development.
  • Increased infrastructure and sponsorship for pediatric clinical trials observed.
  • Pediatric research growth often lacks sufficient investigator expertise in trial design and interpretation.

Purpose of the Study:

  • To highlight essential elements for pediatric phase I/II clinical trial protocols.
  • To emphasize unique considerations for trials involving pediatric populations.
  • To illustrate potential problems arising from non-pediatric-focused trial designs.

Main Methods:

  • Review of pediatric phase I/II clinical trial protocols.
  • Analysis of common design flaws.
  • Case illustrations from practical experience.

Main Results:

  • Pediatric phase I/II protocols vary significantly in quality.
  • Inadequate consideration of pediatric-specific needs can lead to design flaws.
  • Lack of trained pediatric investigator involvement impacts trial integrity.

Conclusions:

  • Careful design of pediatric clinical trials is paramount.
  • Involvement of experienced pediatric investigators is critical for successful trials.
  • Addressing specific pediatric needs in trial design enhances patient safety and data validity.

More Related Videos

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition06:20

Irradiator Commissioning and Dosimetry for Assessment of LQ α and β Parameters, Radiation Dosing Schema, and in vivo Dose Deposition

Published on: March 11, 2021

Related Concept Videos

Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Preclinical Development: Overview01:28

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...